Differentiation potential of CD10+CD24− and CD10−CD24+ progenitors. (A) Flow cytometry analysis of 3-wk cultures on MS5 stromal cells in B or NK cell differentiation assays of CD10+CD24− and CD10+CD24+ progenitors sorted from <10-yr-old BM. The data shown represent six independent experiments performed on cord blood (n = 2) and <10-yr-old (n = 2) and >10-yr-old (n = 2) BM samples. (B) CD4, CD8, CD3, and γδTCR expression analysis of 5-wk cultures on OP9-hDelta1 stromal cells of CD10+CD24− progenitors sorted from cord blood or pediatric BM. The data shown represent five independent experiments performed on cord blood (n = 2) and <10-yr-old (n = 2) and >10-yr-old (n = 1) BM samples. After 5 wk, we recovered an average of 6,000 and 200 T cells (CD4+CD8+ and γδ T cells) from 1,000 CD10+CD24− progenitors sorted from cord blood and BM samples, respectively. (C) Lin−CD34+CD10+ progenitors exhibit a DC potential. (left) A representative 10-d culture in DC differentiation conditions from cord blood–sorted CD10− and CD10+CD24− progenitors is shown. Bar, 10 μm. In the same culture conditions, CD10+CD24+ cells did not survive. (right) Flow cytometry analysis of 10-d cultures of CD10− and CD10+CD24− progenitors. HLA-DR expression is analyzed on CD1a+-gated cells. Numbers in A–C represent percentages of cells. (D) Limiting dilution assay analysis of CD10+CD24− progenitors sorted from cord blood (n = 2) and <10-yr-old (n = 1) and >10-yr-old (n = 1) BM. After 4–5 wk of culture in 96-well plates, means of 20,000, 3,250, and 560 viable cells were recovered from 100 CD10+CD24− progenitors sorted from cord blood, pediatric, and adult BM samples, respectively.